Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04774952
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2021-02-25
Brief Title:
Dose Escalation of RMC-5552 Monotherapy in RelapsedRefractory Solid Tumors
Sponsor:
Revolution Medicines Inc
Organization:
Revolution Medicines Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-25
First Submit QC Date:
February 25 2021
Study First Post Date:
2021-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-16
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL